Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway

1 J. Bruix and M. Sherman, Management of hepatocellular carcinoma: An update, Hepatology53 (2011) 1020–1022; https://doi.org/10.1002/hep.2419910.1002/hep.24199308499121374666Search in Google Scholar

2. U. Asghar and T. Meyer, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J. Hepatol.56 (2012) 686–695; https://doi.org/10.1016/j.jhep.2011.07.03110.1016/j.jhep.2011.07.03121971559Search in Google Scholar

3. S. R. Chen, H.C. Qiu, Y. Hu, Y. Wang and Y. T. Wang, Herbal medicine offered as an initiative therapeutic option for the management of hepatocellular carcinoma, Phytother. Res.30 (2016) 863–877; https://doi.org/10.1002/ptr.559410.1002/ptr.559426879574Search in Google Scholar

4. B. Kocaadam and N. Sanlier, Curcumin, an active component of turmeric (Curcuma longa), and its effects on health, Crit. Rev. Food Sci. Nutr.57 (2017) 2889–2895; https://doi.org/10.1080/10408398.2015.107719510.1080/10408398.2015.107719526528921Search in Google Scholar

5. H. Mahammedi, E. Planchat, M. Pouget, X. Durando, H. Cure, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, E. Gadea, C. Abrial, E. Thivat, P. Chollet and J. C. Eymard, The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study, Oncology90 (2016) 69–78; https://doi.org/10.1159/00044114810.1159/00044114826771576Search in Google Scholar

6. W. Z. Wang, L. Li, M. Y. Liu, X. B. Jin, J. W. Mao, Q. H. Pu, M. J. Meng, X. G. Chen and J. Y. Zhu, Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells, Life Sci.92 (2013) 352–358; https://doi.org/doi:10.1016/j.lfs.2013.01.01310.1016/j.lfs.2013.01.01323352975Search in Google Scholar

7. M. I. James, C. Iwuji, G. Irving, A. Karmokar, J. A. Higgins, N. Griffin-Teal, A. Thomas, P. Greaves, H. Cai, S. R. Patel, B. Morgan, A. Dennison, M. Metcalfe, G. Garcea, D. M. Lloyd, D. P. Berry, W. P. Steward, L. M. Howells and K. Brown, Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy, Cancer Lett.364 (2015) 135–141; https://doi.org/10.1016/j.canlet.2015.05.00510.1016/j.canlet.2015.05.005451014425979230Search in Google Scholar

8. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher and W. P. Steward, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin. Cancer Res.10 (2004) 6847–6854; https://doi.org/10.1158/1078-0432.CCR-04-074410.1158/1078-0432.CCR-04-074415501961Search in Google Scholar

9. D. Ghosh, S. T. Choudhury, S. Ghosh, A. K. Mandal, S. Sarkar, A. Ghosh, K. D. Saha and N. Das, Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat, Chem. Biol. Int.195 (2012) 206–214; https://doi.org/10.1016/j.cbi.2011.12.00410.1016/j.cbi.2011.12.00422197969Search in Google Scholar

10. F. Wang, J. Chen, W. Dai, Z. He, D. Zhai and W. Chen, Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers, Acta Pharm.67 (2017) 597–605; https://doi.org/10.1515/acph-2017-002110.1515/acph-2017-002128858837Search in Google Scholar

11. F. Wang, Z. He, W. Dai, Q. Li, X. Liu, Z. Zhang, D. Zhai, J. Chen and W. Chen, The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis, J. Cancer Res. Ther.11 (2015) 597–605; https://doi.org/10.4103/0973-1482.15908610.4103/0973-1482.159086Search in Google Scholar

12. S. Fulda, Targeting apoptosis for anticancer therapy, Semin. Cancer Biol.31 (2015) 84–88. https://doi.org/10.1016/j.semcancer.2014.05.00210.1016/j.semcancer.2014.05.002Search in Google Scholar

13. F. C. Kischkel, D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim and A. Ashkenazi, Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, Immunity12 (2000) 611–620; https://doi.org/10.1016/s1074-7613(00)80212-510.1016/S1074-7613(00)80212-5Search in Google Scholar

14. J. Chen, W. T. Dai, Z. M. He, L. Gao, X. Huang, J. M. Gong, H. Y. Xing and W. D. Chen, Fabrication and evaluation of curcumin-loaded nanoparticles based on solid lipid as a new type of colloidal drug delivery system, Indian J. Pharm. Sci.75 (2013) 178–184.Search in Google Scholar

15. J. Li and J. Yuan, Caspases in apoptosis and beyond, Oncogene27 (2008) 6194–6206. https://doi.org/10.1038/onc.2008.29710.1038/onc.2008.29718931687Search in Google Scholar